| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.23e-08 | 46 | 77 | 6 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.76e-05 | 188 | 77 | 6 | GO:0005201 | |
| GeneOntologyBiologicalProcess | RNA splicing | HABP4 SRSF2 RBMXL3 DAZAP1 DDX42 UPF1 HNRNPUL1 PDCD7 RBM47 HNRNPA1L3 SRSF9 HNRNPH1 HNRNPH2 METTL14 SYNCRIP | 4.47e-10 | 502 | 77 | 15 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA processing | HABP4 XRN2 SRSF2 RBMXL3 DAZAP1 CPSF6 DDX42 UPF1 HNRNPUL1 RBM47 HNRNPA1L3 SRSF9 HNRNPH1 METTL14 SYNCRIP | 1.60e-09 | 551 | 77 | 15 | GO:0006397 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | SRSF2 RBMXL3 DAZAP1 DDX42 UPF1 HNRNPUL1 RBM47 HNRNPA1L3 SRSF9 HNRNPH1 METTL14 SYNCRIP | 8.30e-09 | 358 | 77 | 12 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | SRSF2 RBMXL3 DAZAP1 DDX42 UPF1 HNRNPUL1 RBM47 HNRNPA1L3 SRSF9 HNRNPH1 METTL14 SYNCRIP | 8.30e-09 | 358 | 77 | 12 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | SRSF2 RBMXL3 DAZAP1 DDX42 UPF1 HNRNPUL1 RBM47 HNRNPA1L3 SRSF9 HNRNPH1 METTL14 SYNCRIP | 9.40e-09 | 362 | 77 | 12 | GO:0000375 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 7.76e-08 | 207 | 77 | 9 | GO:0043484 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | HABP4 XRN2 SRSF2 RBMXL3 DAZAP1 CPSF6 DDX42 TNKS1BP1 UPF1 HNRNPUL1 RBM47 HNRNPA1L3 SRSF9 HNRNPH1 METTL14 SYNCRIP | 2.18e-07 | 917 | 77 | 16 | GO:0016071 |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 8.78e-06 | 129 | 77 | 6 | GO:0048024 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 2.78e-05 | 158 | 77 | 6 | GO:0050684 | |
| GeneOntologyBiologicalProcess | RNA processing | HABP4 XRN2 SRSF2 RBMXL3 DAZAP1 CPSF6 DDX42 UPF1 HNRNPUL1 PDCD7 RBM47 HNRNPA1L3 SRSF9 HNRNPH1 HNRNPH2 METTL14 SYNCRIP | 3.02e-05 | 1500 | 77 | 17 | GO:0006396 |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | SRSF2 RBMXL3 DAZAP1 TNKS1BP1 UPF1 RBM47 SRSF9 METTL14 SYNCRIP | 3.97e-05 | 443 | 77 | 9 | GO:1903311 |
| GeneOntologyBiologicalProcess | cellular response to cycloheximide | 4.12e-05 | 3 | 77 | 2 | GO:0071409 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 9.05e-05 | 63 | 77 | 4 | GO:0033120 | |
| GeneOntologyBiologicalProcess | GABAergic neuron differentiation | 9.57e-05 | 24 | 77 | 3 | GO:0097154 | |
| GeneOntologyBiologicalProcess | response to cycloheximide | 2.04e-04 | 6 | 77 | 2 | GO:0046898 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 2.18e-04 | 79 | 77 | 4 | GO:0000380 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 4.16e-04 | 259 | 77 | 6 | GO:1903313 | |
| GeneOntologyCellularComponent | collagen trimer | 3.48e-08 | 88 | 77 | 7 | GO:0005581 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.26e-06 | 215 | 77 | 8 | GO:0005681 | |
| GeneOntologyCellularComponent | interchromatin granule | 1.33e-04 | 5 | 77 | 2 | GO:0035061 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A2 COL6A1 COL24A1 COL9A1 COL21A1 NTN3 HAPLN2 GPC2 COL1A2 | 1.41e-04 | 530 | 77 | 9 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A2 COL6A1 COL24A1 COL9A1 COL21A1 NTN3 HAPLN2 GPC2 LRRC17 COL1A2 | 1.43e-04 | 656 | 77 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A2 COL6A1 COL24A1 COL9A1 COL21A1 NTN3 HAPLN2 GPC2 LRRC17 COL1A2 | 1.46e-04 | 658 | 77 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | mRNA editing complex | 2.78e-04 | 7 | 77 | 2 | GO:0045293 | |
| GeneOntologyCellularComponent | chromatin | PPP1R10 SRSF2 NKX2-1 CPSF6 TBX21 TLX3 POU3F2 TNKS1BP1 UPF1 IRX1 ARID1A KLF4 PINK1 SP7 KLF2 | 2.85e-04 | 1480 | 77 | 15 | GO:0000785 |
| GeneOntologyCellularComponent | perichromatin fibrils | 3.70e-04 | 8 | 77 | 2 | GO:0005726 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | SRSF2 RBMXL3 DAZAP1 ATXN2 CPSF6 DDX42 UPF1 HNRNPUL1 PDCD7 HNRNPA1L3 HNRNPH1 HNRNPH2 SYNCRIP | 3.89e-04 | 1194 | 77 | 13 | GO:1990904 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.41e-03 | 332 | 77 | 6 | GO:0005788 | |
| Domain | Collagen | 5.33e-08 | 85 | 76 | 7 | IPR008160 | |
| Domain | Collagen | 5.33e-08 | 85 | 76 | 7 | PF01391 | |
| Domain | RRM_1 | SRSF2 RBMXL3 DAZAP1 CPSF6 RBM47 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 1.66e-07 | 208 | 76 | 9 | PF00076 |
| Domain | RRM | SRSF2 RBMXL3 DAZAP1 CPSF6 RBM47 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 2.37e-07 | 217 | 76 | 9 | SM00360 |
| Domain | RRM_dom | SRSF2 RBMXL3 DAZAP1 CPSF6 RBM47 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 3.47e-07 | 227 | 76 | 9 | IPR000504 |
| Domain | RRM | SRSF2 RBMXL3 DAZAP1 CPSF6 RBM47 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 3.88e-07 | 230 | 76 | 9 | PS50102 |
| Domain | - | SRSF2 RBMXL3 DAZAP1 CPSF6 RBM47 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 6.36e-07 | 244 | 76 | 9 | 3.30.70.330 |
| Domain | Nucleotide-bd_a/b_plait | SRSF2 RBMXL3 DAZAP1 CPSF6 RBM47 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 1.01e-06 | 258 | 76 | 9 | IPR012677 |
| Domain | zf-RNPHF | 4.89e-05 | 3 | 76 | 2 | PF08080 | |
| Domain | Znf_CHHC | 4.89e-05 | 3 | 76 | 2 | IPR012996 | |
| Domain | TSPN | 1.08e-04 | 23 | 76 | 3 | SM00210 | |
| Domain | HnRNP_R/Q_splicing_fac | 1.62e-04 | 5 | 76 | 2 | IPR006535 | |
| Domain | Znf_SWIM | 5.77e-04 | 9 | 76 | 2 | IPR007527 | |
| Domain | ZF_SWIM | 5.77e-04 | 9 | 76 | 2 | PS50966 | |
| Domain | Fib_collagen_C | 8.78e-04 | 11 | 76 | 2 | IPR000885 | |
| Domain | COLFI | 8.78e-04 | 11 | 76 | 2 | PF01410 | |
| Domain | NC1_FIB | 8.78e-04 | 11 | 76 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 8.78e-04 | 11 | 76 | 2 | PD002078 | |
| Domain | COLFI | 8.78e-04 | 11 | 76 | 2 | SM00038 | |
| Domain | Laminin_G | 1.70e-03 | 58 | 76 | 3 | IPR001791 | |
| Domain | - | 6.85e-03 | 95 | 76 | 3 | 2.60.120.200 | |
| Domain | Homeobox_CS | 7.00e-03 | 186 | 76 | 4 | IPR017970 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.68e-08 | 44 | 55 | 6 | M27812 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.21e-07 | 67 | 55 | 6 | M26999 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.29e-06 | 90 | 55 | 6 | M631 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.78e-06 | 61 | 55 | 5 | M27103 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.10e-05 | 277 | 55 | 8 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.28e-05 | 283 | 55 | 8 | M13087 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.89e-05 | 41 | 55 | 4 | MM15538 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | XRN2 SRSF2 CPSF6 DDX42 TNKS1BP1 UPF1 PDCD7 SRSF9 HNRNPH1 HNRNPH2 METTL14 | 1.98e-05 | 612 | 55 | 11 | MM15547 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.18e-05 | 50 | 55 | 4 | MM14796 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 5.21e-05 | 19 | 55 | 3 | M27221 | |
| Pathway | WP_MRNA_PROCESSING | XRN2 SRSF2 RBMXL3 DAZAP1 RBM47 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 5.57e-05 | 451 | 55 | 9 | MM15946 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 6.11e-05 | 20 | 55 | 3 | MM15061 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | XRN2 SRSF2 CPSF6 DDX42 TNKS1BP1 UPF1 PDCD7 SRSF9 HNRNPH1 HNRNPH2 METTL14 | 9.15e-05 | 724 | 55 | 11 | M16843 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 9.18e-05 | 61 | 55 | 4 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.11e-04 | 64 | 55 | 4 | M26953 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.26e-04 | 201 | 55 | 6 | MM15411 | |
| Pathway | WP_MRNA_PROCESSING | 1.28e-04 | 126 | 55 | 5 | M39406 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.69e-04 | 212 | 55 | 6 | M14033 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.16e-04 | 76 | 55 | 4 | M27219 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.16e-04 | 76 | 55 | 4 | MM14573 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.16e-04 | 76 | 55 | 4 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.32e-04 | 85 | 55 | 4 | M16441 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.30e-04 | 38 | 55 | 3 | MM14969 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.79e-04 | 42 | 55 | 3 | M7169 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 6.21e-04 | 43 | 55 | 3 | M39565 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 7.58e-04 | 46 | 55 | 3 | M198 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 8.07e-04 | 47 | 55 | 3 | MM14925 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 8.58e-04 | 48 | 55 | 3 | MM15410 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 9.67e-04 | 50 | 55 | 3 | M5583 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.07e-03 | 300 | 55 | 6 | M610 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.15e-03 | 53 | 55 | 3 | MM14566 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.42e-03 | 57 | 55 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.49e-03 | 58 | 55 | 3 | M2049 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.52e-03 | 15 | 55 | 2 | M27161 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.81e-03 | 62 | 55 | 3 | MM15426 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.89e-03 | 63 | 55 | 3 | M11187 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.15e-03 | 140 | 55 | 4 | M587 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.20e-03 | 18 | 55 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.20e-03 | 18 | 55 | 2 | MM14882 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 2.26e-03 | 67 | 55 | 3 | M27694 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 3.00e-03 | 74 | 55 | 3 | M160 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | HABP4 SRSF2 DAZAP1 ATXN2 UPF1 RBM47 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 3.43e-10 | 258 | 78 | 10 | 37794589 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PPP1R10 XRN2 SRSF2 CPSF6 DDX42 TNKS1BP1 UPF1 GPC2 ARHGAP39 HNRNPUL1 ARID1A PDCD7 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 1.94e-09 | 1082 | 78 | 16 | 38697112 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | PPP1R10 XRN2 SRSF2 DAZAP1 ATXN2 CPSF6 DDX42 UPF1 HNRNPUL1 RBM47 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 3.04e-09 | 807 | 78 | 14 | 22681889 |
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | PTOV1 ZSWIM8 XRN2 SRSF2 DAZAP1 CPSF6 ZSWIM6 HNRNPUL1 HNRNPH1 SYNCRIP | 4.36e-09 | 336 | 78 | 10 | 31253590 |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | PPP1R10 DAZAP1 ATXN2 CPSF6 TNKS1BP1 UPF1 HNRNPUL1 HNRNPH2 SYNCRIP | 3.86e-08 | 315 | 78 | 9 | 26777405 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PPP1R10 XRN2 SRSF2 DAZAP1 CPSF6 KRT82 DDX42 GNAS HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 FAM83H SYNCRIP | 5.98e-08 | 1024 | 78 | 14 | 24711643 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | XRN2 SRSF2 DAZAP1 ATXN2 CPSF6 DDX42 UPF1 HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 6.44e-08 | 714 | 78 | 12 | 28302793 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | XRN2 SHROOM3 SRSF2 CPSF6 DDX42 TNKS1BP1 UPF1 GNAS ARID1A HNRNPH1 SYNCRIP | 7.41e-08 | 582 | 78 | 11 | 20467437 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | PTOV1 XRN2 SRSF2 ATXN2 CPSF6 GAS1 UPF1 GNAS HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 1.32e-07 | 922 | 78 | 13 | 27609421 |
| Pubmed | Functional association of human Ki-1/57 with pre-mRNA splicing events. | 2.16e-07 | 6 | 78 | 3 | 19523114 | |
| Pubmed | 2.30e-07 | 114 | 78 | 6 | 31553912 | ||
| Pubmed | 2.69e-07 | 61 | 78 | 5 | 11180952 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | PPP1R10 SRSF2 DAZAP1 CPSF6 DDX42 UPF1 GNAS ARID1A SRSF9 HNRNPH2 SYNCRIP | 2.80e-07 | 665 | 78 | 11 | 30457570 |
| Pubmed | TRAFD1 SRSF2 DAZAP1 ATXN2 CPSF6 TNKS1BP1 PGP HNRNPH1 HNRNPH2 | 2.86e-07 | 399 | 78 | 9 | 35987950 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 3.16e-07 | 197 | 78 | 7 | 22365833 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | XRN2 SRSF2 ATXN2 CPSF6 KRT82 UPF1 HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 3.39e-07 | 678 | 78 | 11 | 30209976 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.65e-07 | 220 | 78 | 7 | 35785414 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PPP1R10 XRN2 ATXN2 CPSF6 TNKS1BP1 UPF1 GNAS HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 METTL14 FAM83H SYNCRIP | 7.13e-07 | 1257 | 78 | 14 | 36526897 |
| Pubmed | 8.02e-07 | 32 | 78 | 4 | 19542561 | ||
| Pubmed | 1.16e-06 | 347 | 78 | 8 | 16033648 | ||
| Pubmed | PPP1R10 SRSF2 ATXN2 CPSF6 UPF1 GNAS HNRNPUL1 ARID1A HNRNPH1 SYNCRIP | 1.19e-06 | 615 | 78 | 10 | 31048545 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | XRN2 TRAFD1 SRSF2 TNKS1BP1 ARHGAP39 HNRNPUL1 PCDH7 SRSF9 HNRNPH1 WDR62 ZNF687 | 1.24e-06 | 774 | 78 | 11 | 15302935 |
| Pubmed | 1.30e-06 | 153 | 78 | 6 | 25037231 | ||
| Pubmed | 1.33e-06 | 244 | 78 | 7 | 29884807 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PPP1R10 XRN2 SRSF2 DAZAP1 ATXN2 CPSF6 DDX42 HNRNPUL1 ARID1A SRSF9 HNRNPH1 SYNCRIP | 1.39e-06 | 954 | 78 | 12 | 36373674 |
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 1.73e-06 | 254 | 78 | 7 | 28431233 | |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 1.78e-06 | 89 | 78 | 5 | 22446626 | |
| Pubmed | 1.89e-06 | 90 | 78 | 5 | 33087562 | ||
| Pubmed | PPP1R10 XRN2 SRSF2 DAZAP1 ATXN2 HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 WDR62 SYNCRIP | 1.90e-06 | 809 | 78 | 11 | 32129710 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | PTOV1 PPP1R10 XRN2 SRSF2 DAZAP1 CPSF6 DDX42 HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 2.02e-06 | 989 | 78 | 12 | 36424410 |
| Pubmed | XRN2 DAZAP1 DDX42 TNKS1BP1 UPF1 GNAS HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 | 2.23e-06 | 660 | 78 | 10 | 32780723 | |
| Pubmed | 2.56e-06 | 172 | 78 | 6 | 26336360 | ||
| Pubmed | 2.86e-06 | 274 | 78 | 7 | 34244482 | ||
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 2.87e-06 | 98 | 78 | 5 | 21942715 | |
| Pubmed | PPP1R10 COL24A1 XKR7 PKDCC PDCD7 KLF4 SRSF9 SYDE1 HNRNPH1 COL1A2 | 3.27e-06 | 689 | 78 | 10 | 36543142 | |
| Pubmed | XRN2 ATXN2 CPSF6 DDX42 UPF1 HNRNPUL1 HNRNPH1 HNRNPH2 SYNCRIP | 4.07e-06 | 551 | 78 | 9 | 34728620 | |
| Pubmed | XRN2 SRSF2 ATXN2 CPSF6 UPF1 HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 4.42e-06 | 713 | 78 | 10 | 29802200 | |
| Pubmed | 4.83e-06 | 421 | 78 | 8 | 34650049 | ||
| Pubmed | 4.85e-06 | 109 | 78 | 5 | 12226669 | ||
| Pubmed | 4.85e-06 | 109 | 78 | 5 | 29511296 | ||
| Pubmed | Regulation of endothelial hemoglobin alpha expression by Kruppel-like factors. | 4.97e-06 | 2 | 78 | 2 | 28825355 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 23358112 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 27597528 | ||
| Pubmed | HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4. | 4.97e-06 | 2 | 78 | 2 | 26372274 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 21182892 | ||
| Pubmed | KLF2 and KLF4 control endothelial identity and vascular integrity. | 4.97e-06 | 2 | 78 | 2 | 28239661 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 19968965 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 25172663 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 37315534 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 36789992 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 30584064 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PPP1R10 XRN2 SRSF2 TLX3 DDX42 HNRNPUL1 ARID1A KLF4 SRSF9 HNRNPH1 HNRNPH2 ZNF687 SYNCRIP | 5.74e-06 | 1294 | 78 | 13 | 30804502 |
| Pubmed | 6.31e-06 | 115 | 78 | 5 | 17332742 | ||
| Pubmed | 7.23e-06 | 206 | 78 | 6 | 22174317 | ||
| Pubmed | 8.07e-06 | 210 | 78 | 6 | 16537572 | ||
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 8.45e-06 | 57 | 78 | 4 | 17932509 | |
| Pubmed | Vegfa regulates perichondrial vascularity and osteoblast differentiation in bone development. | 8.64e-06 | 18 | 78 | 3 | 25977369 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 9.49e-06 | 462 | 78 | 8 | 31138677 | |
| Pubmed | 1.05e-05 | 220 | 78 | 6 | 24550385 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.38e-05 | 135 | 78 | 5 | 28675934 | |
| Pubmed | The transcriptional regulator MEIS2 sets up the ground state for palatal osteogenesis in mice. | 1.40e-05 | 21 | 78 | 3 | 32169905 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 38099436 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 10456323 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 28167653 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 19412182 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 33448926 | ||
| Pubmed | ERK5 regulates muscle cell fusion through Klf transcription factors. | 1.49e-05 | 3 | 78 | 2 | 21316587 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 34097350 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 29739838 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 32366676 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 14980514 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 21068389 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 7499401 | ||
| Pubmed | COL4A2 PPP1R10 XRN2 TRAFD1 DAZAP1 ATXN2 CPSF6 UPF1 HNRNPUL1 QSOX2 FAM83H | 1.50e-05 | 1007 | 78 | 11 | 34597346 | |
| Pubmed | ZSWIM8 XRN2 SRSF2 DDX42 TNKS1BP1 UPF1 HNRNPUL1 ARID1A SYNCRIP | 1.58e-05 | 653 | 78 | 9 | 22586326 | |
| Pubmed | Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex. | 1.62e-05 | 22 | 78 | 3 | 18377426 | |
| Pubmed | 1.68e-05 | 239 | 78 | 6 | 26641092 | ||
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | PTOV1 TRAFD1 DAZAP1 NTN3 DDX42 PKDCC TNKS1BP1 ZSWIM6 SYDE1 HNRNPH1 SYNCRIP | 1.71e-05 | 1021 | 78 | 11 | 26760575 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 1.93e-05 | 670 | 78 | 9 | 22990118 | |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 2.07e-05 | 248 | 78 | 6 | 27926873 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.14e-05 | 148 | 78 | 5 | 32538781 | |
| Pubmed | Mammalian SP/KLF transcription factors: bring in the family. | 2.41e-05 | 25 | 78 | 3 | 15820306 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.59e-05 | 154 | 78 | 5 | 16055720 | |
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 27814941 | ||
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 12874293 | ||
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 23430263 | ||
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 22495359 | ||
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 21482710 | ||
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 34592197 | ||
| Pubmed | Thyroid bud morphogenesis requires CDC42- and SHROOM3-dependent apical constriction. | 2.97e-05 | 4 | 78 | 2 | 26772200 | |
| Pubmed | 3.50e-05 | 723 | 78 | 9 | 34133714 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 3.54e-05 | 908 | 78 | 10 | 19274049 | |
| Pubmed | SRSF2 DAZAP1 ATXN2 CPSF6 UPF1 HNRNPUL1 HNRNPH1 HNRNPH2 SYNCRIP | 3.58e-05 | 725 | 78 | 9 | 27025967 | |
| Pubmed | 4.37e-05 | 418 | 78 | 7 | 35338135 | ||
| Pubmed | 4.85e-05 | 754 | 78 | 9 | 35906200 | ||
| Pubmed | 4.85e-05 | 425 | 78 | 7 | 21081503 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 38470475 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 2030943 | ||
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 19495417 | ||
| Pubmed | Vax1 Plays an Indirect Role in the Etiology of Murine Cleft Palate. | 4.94e-05 | 5 | 78 | 2 | 28771384 | |
| Interaction | HNRNPUL1 interactions | XRN2 NKX2-1 CPSF6 TLX3 KLHDC7B HNRNPUL1 KLF4 SRSF9 HNRNPH1 HNRNPH2 METTL14 SYNCRIP | 8.60e-09 | 351 | 77 | 12 | int:HNRNPUL1 |
| Interaction | DAZL interactions | 8.19e-08 | 145 | 77 | 8 | int:DAZL | |
| Interaction | FUS interactions | PPP1R10 XRN2 SRSF2 NKX2-1 CPSF6 DDX42 UPF1 GNAS HNRNPUL1 ARID1A SRSF9 HNRNPH1 METTL14 PINK1 SYNCRIP | 1.47e-07 | 757 | 77 | 15 | int:FUS |
| Interaction | FUBP3 interactions | DAZAP1 ATXN2 CPSF6 UPF1 HNRNPUL1 RBM47 HNRNPH1 PINK1 SYNCRIP SP7 | 1.91e-07 | 297 | 77 | 10 | int:FUBP3 |
| Interaction | MIR29A interactions | 1.01e-06 | 87 | 77 | 6 | int:MIR29A | |
| Interaction | RC3H2 interactions | XRN2 SRSF2 ATXN2 CPSF6 KRT82 TNKS1BP1 UPF1 HNRNPUL1 RBM47 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 1.33e-06 | 667 | 77 | 13 | int:RC3H2 |
| Interaction | RBMX interactions | XRN2 SRSF2 NKX2-1 CPSF6 UPF1 HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 METTL14 PINK1 | 1.37e-06 | 461 | 77 | 11 | int:RBMX |
| Interaction | MIR128-1 interactions | 1.40e-06 | 92 | 77 | 6 | int:MIR128-1 | |
| Interaction | CELF1 interactions | 1.51e-06 | 288 | 77 | 9 | int:CELF1 | |
| Interaction | XRN2 interactions | XRN2 CPSF6 UPF1 ARHGAP39 HNRNPUL1 SRSF9 SYDE1 HNRNPH1 SYNCRIP SP7 | 1.84e-06 | 381 | 77 | 10 | int:XRN2 |
| Interaction | FUBP1 interactions | 2.70e-06 | 309 | 77 | 9 | int:FUBP1 | |
| Interaction | SYNCRIP interactions | HABP4 XRN2 ATXN2 CPSF6 DDX42 UPF1 HNRNPUL1 PCDH7 HNRNPH1 HNRNPH2 METTL14 PINK1 SYNCRIP | 3.14e-06 | 721 | 77 | 13 | int:SYNCRIP |
| Interaction | SMG7 interactions | 3.50e-06 | 319 | 77 | 9 | int:SMG7 | |
| Interaction | STIP1 interactions | XRN2 SRSF2 ATXN2 PKDCC UPF1 ARHGAP39 PGP HNRNPUL1 PCDH7 SRSF9 HNRNPH1 METTL14 FAM83H PINK1 SYNCRIP | 5.16e-06 | 1006 | 77 | 15 | int:STIP1 |
| Interaction | MECP2 interactions | PPP1R10 XRN2 SRSF2 NKX2-1 CPSF6 DDX42 TNKS1BP1 UPF1 GPC2 ARHGAP39 HNRNPUL1 ARID1A PDCD7 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 5.56e-06 | 1287 | 77 | 17 | int:MECP2 |
| Interaction | SNRPC interactions | PPP1R10 HABP4 CPSF6 DDX42 UPF1 HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 6.60e-06 | 440 | 77 | 10 | int:SNRPC |
| Interaction | ATXN1 interactions | PPP1R10 ZSWIM8 SRSF2 DAZAP1 ATXN2 CPSF6 DDX42 UPF1 GNAS ARID1A SRSF9 HNRNPH1 HNRNPH2 SYNCRIP SP7 | 7.62e-06 | 1039 | 77 | 15 | int:ATXN1 |
| Interaction | NCBP1 interactions | 7.93e-06 | 353 | 77 | 9 | int:NCBP1 | |
| Interaction | MIR29B1 interactions | 8.75e-06 | 73 | 77 | 5 | int:MIR29B1 | |
| Interaction | COL4A2 interactions | 1.00e-05 | 75 | 77 | 5 | int:COL4A2 | |
| Interaction | HNRNPDL interactions | SRSF2 CPSF6 UPF1 HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 METTL14 SYNCRIP | 1.01e-05 | 364 | 77 | 9 | int:HNRNPDL |
| Interaction | MIR16-1 interactions | 1.07e-05 | 76 | 77 | 5 | int:MIR16-1 | |
| Interaction | MIR92A1 interactions | 1.21e-05 | 78 | 77 | 5 | int:MIR92A1 | |
| Interaction | RBMS1 interactions | 1.43e-05 | 207 | 77 | 7 | int:RBMS1 | |
| Interaction | ILF2 interactions | XRN2 SRSF2 ATXN2 NKX2-1 CPSF6 UPF1 HNRNPUL1 KLF4 HNRNPH1 METTL14 SYNCRIP | 1.43e-05 | 590 | 77 | 11 | int:ILF2 |
| Interaction | COL9A1 interactions | 1.49e-05 | 13 | 77 | 3 | int:COL9A1 | |
| Interaction | MIR199A1 interactions | 1.74e-05 | 84 | 77 | 5 | int:MIR199A1 | |
| Interaction | MIR17 interactions | 1.84e-05 | 85 | 77 | 5 | int:MIR17 | |
| Interaction | MIR18B interactions | 1.84e-05 | 85 | 77 | 5 | int:MIR18B | |
| Interaction | MIR93 interactions | 1.84e-05 | 85 | 77 | 5 | int:MIR93 | |
| Interaction | HNRNPK interactions | PPP1R10 XRN2 SRSF2 DAZAP1 CPSF6 TNKS1BP1 UPF1 PCDH7 HNRNPH1 HNRNPH2 METTL14 PINK1 SYNCRIP | 1.91e-05 | 853 | 77 | 13 | int:HNRNPK |
| Interaction | MIR138-2 interactions | 2.18e-05 | 88 | 77 | 5 | int:MIR138-2 | |
| Interaction | SRSF9 interactions | 2.37e-05 | 224 | 77 | 7 | int:SRSF9 | |
| Interaction | MIR155 interactions | 2.71e-05 | 92 | 77 | 5 | int:MIR155 | |
| Interaction | HNRNPA2B1 interactions | XRN2 SRSF2 ATXN2 CPSF6 UPF1 PCDH7 SRSF9 HNRNPH1 HNRNPH2 METTL14 PINK1 SYNCRIP | 2.72e-05 | 754 | 77 | 12 | int:HNRNPA2B1 |
| Interaction | MIR19B2 interactions | 3.01e-05 | 94 | 77 | 5 | int:MIR19B2 | |
| Interaction | MIRLET7F1 interactions | 3.01e-05 | 94 | 77 | 5 | int:MIRLET7F1 | |
| Interaction | OBSL1 interactions | PPP1R10 XRN2 SHROOM3 SRSF2 DAZAP1 CPSF6 KRT82 DDX42 HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 3.42e-05 | 902 | 77 | 13 | int:OBSL1 |
| Interaction | MIRLET7C interactions | 3.50e-05 | 97 | 77 | 5 | int:MIRLET7C | |
| Interaction | MIRLET7F2 interactions | 3.50e-05 | 97 | 77 | 5 | int:MIRLET7F2 | |
| Interaction | RBM39 interactions | PPP1R10 XRN2 SRSF2 DAZAP1 ATXN2 CPSF6 DDX42 UPF1 HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 PINK1 SYNCRIP | 3.55e-05 | 1042 | 77 | 14 | int:RBM39 |
| Interaction | CRY1 interactions | 3.64e-05 | 162 | 77 | 6 | int:CRY1 | |
| Interaction | MIR128-2 interactions | 3.86e-05 | 99 | 77 | 5 | int:MIR128-2 | |
| Interaction | MIR19A interactions | 4.05e-05 | 100 | 77 | 5 | int:MIR19A | |
| Interaction | MIRLET7B interactions | 4.25e-05 | 101 | 77 | 5 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 4.25e-05 | 101 | 77 | 5 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 4.25e-05 | 101 | 77 | 5 | int:MIR25 | |
| Interaction | NONO interactions | PPP1R10 HABP4 NKX2-1 CPSF6 DDX42 PCDH7 HNRNPH1 HNRNPH2 METTL14 PINK1 | 4.42e-05 | 549 | 77 | 10 | int:NONO |
| Interaction | MIR7-1 interactions | 4.67e-05 | 103 | 77 | 5 | int:MIR7-1 | |
| Interaction | MIR19B1 interactions | 4.89e-05 | 104 | 77 | 5 | int:MIR19B1 | |
| Interaction | MIR34A interactions | 4.89e-05 | 104 | 77 | 5 | int:MIR34A | |
| Interaction | RC3H1 interactions | SRSF2 ATXN2 CPSF6 TNKS1BP1 UPF1 HNRNPUL1 RBM47 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 5.04e-05 | 677 | 77 | 11 | int:RC3H1 |
| Interaction | MYCN interactions | HABP4 XRN2 SHROOM3 SRSF2 DAZAP1 ATXN2 CPSF6 EFCC1 UPF1 HNRNPUL1 ARID1A SRSF9 HNRNPH1 HNRNPH2 SYNCRIP SP7 | 5.13e-05 | 1373 | 77 | 16 | int:MYCN |
| Interaction | FXR1 interactions | HABP4 DAZAP1 ATXN2 CPSF6 KCNN1 UPF1 HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 PINK1 | 5.18e-05 | 679 | 77 | 11 | int:FXR1 |
| Interaction | VHL interactions | COL4A2 COL6A1 COL9A1 TRAFD1 ATXN2 DACT2 ARID1A KLF4 HNRNPH1 HNRNPH2 | 5.30e-05 | 561 | 77 | 10 | int:VHL |
| Interaction | MIRLET7E interactions | 5.35e-05 | 106 | 77 | 5 | int:MIRLET7E | |
| Interaction | PEG10 interactions | 5.35e-05 | 106 | 77 | 5 | int:PEG10 | |
| Interaction | NUPR1 interactions | XRN2 DAZAP1 DDX42 TNKS1BP1 UPF1 GNAS HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 5.46e-05 | 683 | 77 | 11 | int:NUPR1 |
| Interaction | HNRNPA1 interactions | XRN2 DAZAP1 ATXN2 CPSF6 UPF1 HNRNPUL1 PCDH7 SRSF9 HNRNPH1 HNRNPH2 METTL14 PINK1 SYNCRIP | 5.52e-05 | 945 | 77 | 13 | int:HNRNPA1 |
| Interaction | GLUD1 interactions | 5.82e-05 | 258 | 77 | 7 | int:GLUD1 | |
| Interaction | MIRLET7A1 interactions | 5.85e-05 | 108 | 77 | 5 | int:MIRLET7A1 | |
| Interaction | YAP1 interactions | PPP1R10 XRN2 SRSF2 CPSF6 POU3F2 TNKS1BP1 UPF1 GNAS HNRNPUL1 ARID1A SH3D21 HNRNPH1 PINK1 SYNCRIP | 6.09e-05 | 1095 | 77 | 14 | int:YAP1 |
| Interaction | MIR34B interactions | 6.39e-05 | 110 | 77 | 5 | int:MIR34B | |
| Interaction | MAGOH interactions | 6.73e-05 | 264 | 77 | 7 | int:MAGOH | |
| Interaction | ALG13 interactions | 7.18e-05 | 183 | 77 | 6 | int:ALG13 | |
| Interaction | WWP2 interactions | PPP1R10 XRN2 SRSF2 DAZAP1 ATXN2 CPSF6 UPF1 GNAS HNRNPUL1 ARID1A HNRNPH1 SYNCRIP | 7.71e-05 | 840 | 77 | 12 | int:WWP2 |
| Interaction | PHB1 interactions | COL6A1 SRSF2 DAZAP1 ATXN2 NKX2-1 CPSF6 UPF1 HNRNPUL1 ARID1A PCDH7 HNRNPH1 HNRNPH2 METTL14 SYNCRIP | 7.99e-05 | 1123 | 77 | 14 | int:PHB1 |
| Interaction | CUL2 interactions | PTOV1 SRSF2 DAZAP1 HNRNPUL1 ARID1A KLF4 HNRNPH1 HNRNPH2 METTL14 SYNCRIP | 8.17e-05 | 591 | 77 | 10 | int:CUL2 |
| Interaction | TIA1 interactions | 8.69e-05 | 275 | 77 | 7 | int:TIA1 | |
| Interaction | AR interactions | USP2 XRN2 DAZAP1 CPSF6 TLX3 DDX42 GNAS HNRNPUL1 ARID1A KLF4 SRSF9 HNRNPH1 HNRNPH2 | 9.03e-05 | 992 | 77 | 13 | int:AR |
| Interaction | HDLBP interactions | PPP1R10 SRSF2 RBMXL3 DAZAP1 CPSF6 UPF1 GNAS RBM47 SRSF9 METTL14 PINK1 SYNCRIP | 9.13e-05 | 855 | 77 | 12 | int:HDLBP |
| Interaction | CDC5L interactions | XRN2 SHROOM3 SRSF2 CPSF6 DDX42 TNKS1BP1 UPF1 GNAS ARID1A SRSF9 HNRNPH1 SYNCRIP | 9.13e-05 | 855 | 77 | 12 | int:CDC5L |
| Interaction | PABPN1 interactions | 9.35e-05 | 192 | 77 | 6 | int:PABPN1 | |
| Interaction | PAIP2 interactions | 9.89e-05 | 63 | 77 | 4 | int:PAIP2 | |
| Interaction | PPIE interactions | 1.02e-04 | 282 | 77 | 7 | int:PPIE | |
| Interaction | EIF5A interactions | 1.04e-04 | 283 | 77 | 7 | int:EIF5A | |
| Interaction | HSF1 interactions | XRN2 SRSF2 ATXN2 CPSF6 PGP HNRNPUL1 SRSF9 HNRNPH1 ZNF687 SYNCRIP | 1.05e-04 | 609 | 77 | 10 | int:HSF1 |
| Interaction | NSRP1 interactions | 1.08e-04 | 197 | 77 | 6 | int:NSRP1 | |
| Interaction | NXF2 interactions | 1.12e-04 | 65 | 77 | 4 | int:NXF2 | |
| Interaction | EIF4A3 interactions | SRSF2 CPSF6 UPF1 HNRNPUL1 SRSF9 HNRNPH1 HNRNPH2 PINK1 SYNCRIP | 1.18e-04 | 499 | 77 | 9 | int:EIF4A3 |
| Interaction | HNRNPUL2 interactions | 1.24e-04 | 291 | 77 | 7 | int:HNRNPUL2 | |
| Interaction | COLGALT2 interactions | 1.26e-04 | 67 | 77 | 4 | int:COLGALT2 | |
| Interaction | ECT2 interactions | XRN2 SRSF2 RBMXL3 UPF1 GNAS HNRNPUL1 ARID1A RBM47 SRSF9 HNRNPH2 FAM83H SYNCRIP | 1.29e-04 | 887 | 77 | 12 | int:ECT2 |
| Interaction | MIR138-1 interactions | 1.33e-04 | 68 | 77 | 4 | int:MIR138-1 | |
| Interaction | HNRNPC interactions | XRN2 CPSF6 ADAM30 UPF1 ARID1A RBM47 HNRNPH1 METTL14 PINK1 SYNCRIP | 1.45e-04 | 634 | 77 | 10 | int:HNRNPC |
| Interaction | MIR9-3 interactions | 1.49e-04 | 70 | 77 | 4 | int:MIR9-3 | |
| Interaction | BRD7 interactions | XRN2 SRSF2 CPSF6 TLX3 HNRNPUL1 ARID1A HECA HNRNPH1 SYNCRIP SP7 | 1.51e-04 | 637 | 77 | 10 | int:BRD7 |
| Interaction | ZFR interactions | 1.52e-04 | 301 | 77 | 7 | int:ZFR | |
| Interaction | SNRPB interactions | PPP1R10 CPSF6 DDX42 UPF1 PDCD7 SRSF9 HNRNPH1 METTL14 SYNCRIP | 1.54e-04 | 517 | 77 | 9 | int:SNRPB |
| Interaction | MIR140 interactions | 1.58e-04 | 71 | 77 | 4 | int:MIR140 | |
| Interaction | MIR122 interactions | 1.58e-04 | 71 | 77 | 4 | int:MIR122 | |
| Interaction | MIR29B2 interactions | 1.58e-04 | 71 | 77 | 4 | int:MIR29B2 | |
| Interaction | TAF15 interactions | 1.64e-04 | 408 | 77 | 8 | int:TAF15 | |
| Interaction | MIR20A interactions | 1.85e-04 | 74 | 77 | 4 | int:MIR20A | |
| Interaction | MIR15A interactions | 1.95e-04 | 75 | 77 | 4 | int:MIR15A | |
| Interaction | ARIH2 interactions | 1.97e-04 | 314 | 77 | 7 | int:ARIH2 | |
| Interaction | HNRNPR interactions | 2.01e-04 | 536 | 77 | 9 | int:HNRNPR | |
| Interaction | BGN interactions | 2.02e-04 | 30 | 77 | 3 | int:BGN | |
| Interaction | MIR7-3 interactions | 2.05e-04 | 76 | 77 | 4 | int:MIR7-3 | |
| Interaction | MIR199A2 interactions | 2.05e-04 | 76 | 77 | 4 | int:MIR199A2 | |
| Cytoband | 8q24.3 | 4.31e-05 | 113 | 78 | 4 | 8q24.3 | |
| Cytoband | 7q22.1 | 9.66e-04 | 113 | 78 | 3 | 7q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q24 | 3.20e-03 | 355 | 78 | 4 | chr8q24 | |
| GeneFamily | Collagens | 3.60e-09 | 46 | 52 | 6 | 490 | |
| GeneFamily | RNA binding motif containing | SRSF2 RBMXL3 DAZAP1 CPSF6 RBM47 SRSF9 HNRNPH1 HNRNPH2 SYNCRIP | 8.76e-09 | 213 | 52 | 9 | 725 |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 2.88e-04 | 9 | 52 | 2 | 90 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 5.26e-04 | 12 | 52 | 2 | 737 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 1.21e-03 | 18 | 52 | 2 | 624 | |
| Coexpression | NABA_COLLAGENS | 3.68e-09 | 44 | 78 | 6 | M3005 | |
| Coexpression | NABA_COLLAGENS | 1.81e-07 | 43 | 78 | 5 | MM17060 | |
| Coexpression | NABA_CORE_MATRISOME | 1.65e-06 | 275 | 78 | 8 | M5884 | |
| Coexpression | NABA_CORE_MATRISOME | 1.61e-05 | 270 | 78 | 7 | MM17057 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | 4.95e-05 | 322 | 78 | 7 | MM3786 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 6.46e-05 | 141 | 78 | 5 | M10381 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_TIP_CELL | 7.38e-05 | 145 | 78 | 5 | M45693 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 7.62e-05 | 146 | 78 | 5 | MM973 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.59e-09 | 190 | 78 | 8 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-08 | 177 | 78 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-08 | 177 | 78 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.24e-08 | 189 | 78 | 7 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.56e-08 | 191 | 78 | 7 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.72e-08 | 192 | 78 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-08 | 192 | 78 | 7 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-08 | 192 | 78 | 7 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-08 | 192 | 78 | 7 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 4.72e-08 | 192 | 78 | 7 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.89e-08 | 193 | 78 | 7 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.07e-08 | 194 | 78 | 7 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.07e-08 | 194 | 78 | 7 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.07e-08 | 194 | 78 | 7 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.25e-08 | 195 | 78 | 7 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.44e-08 | 196 | 78 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 5.83e-08 | 198 | 78 | 7 | 3d76393e72eed59b4dd16130ef5dd1d331ba5711 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.83e-08 | 198 | 78 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.83e-08 | 198 | 78 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.03e-08 | 199 | 78 | 7 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.25e-08 | 200 | 78 | 7 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.25e-08 | 200 | 78 | 7 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.25e-08 | 200 | 78 | 7 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.42e-07 | 157 | 78 | 6 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-07 | 159 | 78 | 6 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.46e-07 | 170 | 78 | 6 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.63e-07 | 180 | 78 | 6 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|lymphoid / Lineage, cell class and subclass | 8.23e-07 | 98 | 78 | 5 | 4da11182885d5f2673e85bd9c5717939b0268427 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 8.67e-07 | 184 | 78 | 6 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.01e-06 | 189 | 78 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-06 | 189 | 78 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-06 | 191 | 78 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related-OPC|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-06 | 192 | 78 | 6 | 5d9bc234f01c73b2531edf8960588d5b6cf260a7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-27|World / Primary Cells by Cluster | 1.11e-06 | 192 | 78 | 6 | cf989f26c0ebdc0cd12e1e41958f063e4fa3e468 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-06 | 192 | 78 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-06 | 192 | 78 | 6 | e6d115143ced6a0d9fe7c98acd3f730bac83f66b | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 193 | 78 | 6 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.15e-06 | 193 | 78 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.18e-06 | 194 | 78 | 6 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.22e-06 | 195 | 78 | 6 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 1.25e-06 | 196 | 78 | 6 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.25e-06 | 196 | 78 | 6 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 1.25e-06 | 196 | 78 | 6 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.25e-06 | 196 | 78 | 6 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.29e-06 | 197 | 78 | 6 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-06 | 197 | 78 | 6 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.29e-06 | 197 | 78 | 6 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.29e-06 | 197 | 78 | 6 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.29e-06 | 197 | 78 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.29e-06 | 197 | 78 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | 11.5-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 1.29e-06 | 197 | 78 | 6 | 9a053a32ff9c3a85ef9a3382453acd619cc48546 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-06 | 198 | 78 | 6 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-06 | 199 | 78 | 6 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.37e-06 | 199 | 78 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.37e-06 | 199 | 78 | 6 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.37e-06 | 199 | 78 | 6 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-06 | 199 | 78 | 6 | da016849b804fbf80edbfa8f8f56c9df8bbf2d51 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-06 | 200 | 78 | 6 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.41e-06 | 200 | 78 | 6 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | 15-Airway|15 / Age, Tissue, Lineage and Cell class | 1.41e-06 | 200 | 78 | 6 | ba4b8d5becf81351901c2ecac74ffa28e29586f3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-06 | 200 | 78 | 6 | 0f7431f670f3a175377cefae3479403a881bb8fb | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-06 | 200 | 78 | 6 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.14e-06 | 136 | 78 | 5 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.14e-06 | 136 | 78 | 5 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.36e-06 | 153 | 78 | 5 | 79c4f4ccdc8249c8461075c73491bc3b2d13344a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.87e-06 | 159 | 78 | 5 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.03e-05 | 164 | 78 | 5 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-05 | 167 | 78 | 5 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-05 | 167 | 78 | 5 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-05 | 170 | 78 | 5 | dfef8f79960979335b86b4730f224239b40735d5 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-05 | 170 | 78 | 5 | fb6098137d010175978596bc382e9ecba9c3891e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 171 | 78 | 5 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 175 | 78 | 5 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 175 | 78 | 5 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 175 | 78 | 5 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-05 | 178 | 78 | 5 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | Pericytes-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.53e-05 | 178 | 78 | 5 | a2448d868da2abe48c394c51264aad03e866dfec | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 179 | 78 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-05 | 180 | 78 | 5 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.62e-05 | 180 | 78 | 5 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-05 | 180 | 78 | 5 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.62e-05 | 180 | 78 | 5 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.62e-05 | 180 | 78 | 5 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 181 | 78 | 5 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 181 | 78 | 5 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 181 | 78 | 5 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-05 | 182 | 78 | 5 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.70e-05 | 182 | 78 | 5 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-05 | 182 | 78 | 5 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-05 | 183 | 78 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-05 | 183 | 78 | 5 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.80e-05 | 184 | 78 | 5 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-05 | 184 | 78 | 5 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 184 | 78 | 5 | 89ac32e374a4379e4a6c6ea7603b1378b77c147f | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 184 | 78 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 184 | 78 | 5 | 4df6027fa635996c1eddb920f88a5265772df1cd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-05 | 185 | 78 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.84e-05 | 185 | 78 | 5 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-05 | 185 | 78 | 5 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.84e-05 | 185 | 78 | 5 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| Computational | RNA splicing. | 1.64e-04 | 65 | 46 | 4 | MODULE_183 | |
| Drug | GK-101 | 1.35e-07 | 36 | 77 | 5 | CID000161853 | |
| Drug | Madecassol | 4.77e-07 | 46 | 77 | 5 | CID000108062 | |
| Drug | d-indobufen | 7.30e-07 | 50 | 77 | 5 | CID000044562 | |
| Drug | ridogrel | 8.90e-07 | 52 | 77 | 5 | CID005362391 | |
| Drug | NSC49633 | 9.80e-07 | 53 | 77 | 5 | CID000023340 | |
| Drug | AC1LAKND | 2.16e-06 | 62 | 77 | 5 | CID000470146 | |
| Drug | poly(G | 2.45e-06 | 114 | 77 | 6 | CID000439502 | |
| Drug | BAPN | 4.24e-06 | 71 | 77 | 5 | CID000001647 | |
| Drug | malotilate | 4.24e-06 | 71 | 77 | 5 | CID000004006 | |
| Drug | AC1NMZ1B | 5.56e-06 | 75 | 77 | 5 | CID005034185 | |
| Drug | strontium ranelate | 6.34e-06 | 77 | 77 | 5 | CID006918182 | |
| Drug | halofuginone lactate | 1.03e-05 | 85 | 77 | 5 | CID000062891 | |
| Drug | 4-hydroxyproline | 1.44e-05 | 91 | 77 | 5 | CID000000825 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.85e-05 | 162 | 77 | 6 | CID000072363 | |
| Drug | S-2-pentyl-4-pentynoic hydroxamic acid | USP2 SHROOM3 TRAFD1 SRSF2 TCF19 TRH KCNN1 ARC ARID1A QSOX2 WDR62 SYNCRIP | 2.22e-05 | 834 | 77 | 12 | ctd:C513635 |
| Drug | ticlopidine | 2.62e-05 | 103 | 77 | 5 | CID000005472 | |
| Drug | AC1NRA5C | 2.77e-05 | 174 | 77 | 6 | CID005287709 | |
| Drug | hyaluronan | 3.06e-05 | 263 | 77 | 7 | CID000024759 | |
| Drug | hydroxylysine | 3.44e-05 | 109 | 77 | 5 | CID000001029 | |
| Drug | AC1L1C2F | 3.60e-05 | 110 | 77 | 5 | CID000001711 | |
| Drug | PPACK | 4.09e-05 | 113 | 77 | 5 | CID003036757 | |
| Drug | AC1L9732 | 4.27e-05 | 114 | 77 | 5 | CID000439300 | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 4.39e-05 | 189 | 77 | 6 | 4304_UP | |
| Drug | Tranilast sodium | 4.45e-05 | 115 | 77 | 5 | CID000005527 | |
| Drug | SC-560; Down 200; 10uM; MCF7; HT_HG-U133A | 5.23e-05 | 195 | 77 | 6 | 6870_DN | |
| Drug | Ethacrynic acid [58-54-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 5.23e-05 | 195 | 77 | 6 | 3181_UP | |
| Drug | Ofloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 3673_DN | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 5.53e-05 | 197 | 77 | 6 | 6089_UP | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 5.53e-05 | 197 | 77 | 6 | 6514_UP | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; HL60; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 3033_UP | |
| Drug | Selara | 6.63e-05 | 125 | 77 | 5 | CID000150310 | |
| Drug | 2-imidazolidone-4-carboxylic acid | 6.74e-05 | 4 | 77 | 2 | CID000089477 | |
| Drug | 2-(ethylsulfonyl)ethanol | 7.88e-05 | 210 | 77 | 6 | CID000010549 | |
| Drug | DMSe | 8.58e-05 | 132 | 77 | 5 | CID000020796 | |
| Drug | pirfenidone | 1.06e-04 | 138 | 77 | 5 | CID000040632 | |
| Drug | DL-penicillamine | 1.10e-04 | 139 | 77 | 5 | CID000004727 | |
| Drug | PCR 4099 | 1.10e-04 | 139 | 77 | 5 | CID000002806 | |
| Drug | AC1Q6PCP | 1.30e-04 | 230 | 77 | 6 | CID000005267 | |
| Drug | candesartan cilexetil | 1.34e-04 | 145 | 77 | 5 | CID000002540 | |
| Drug | ethyl protocatechuate | 1.68e-04 | 6 | 77 | 2 | ctd:C018063 | |
| Drug | AC1L1AUZ | 1.94e-04 | 157 | 77 | 5 | CID000001160 | |
| Drug | prostacyclin sodium salt | 2.04e-04 | 250 | 77 | 6 | CID000000159 | |
| Disease | cortical surface area measurement | COL24A1 SHROOM3 ATXN2 CPSF6 GAS1 TLX3 PKDCC ARHGAP39 HNRNPA1L3 PCDH7 HNRNPH1 SP7 | 1.40e-04 | 1345 | 75 | 12 | EFO_0010736 |
| Disease | creatinine measurement | COL4A2 SHROOM3 TRH GNAS ARID1A KLF4 RBM47 QSOX2 OPLAH SHISA8 | 2.07e-04 | 995 | 75 | 10 | EFO_0004518 |
| Disease | Neuroblastoma | 2.36e-04 | 47 | 75 | 3 | C0027819 | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 2.83e-04 | 10 | 75 | 2 | C0268363 | |
| Disease | biological sex | 3.05e-04 | 230 | 75 | 5 | PATO_0000047 | |
| Disease | complement C1q tumor necrosis factor-related protein 5 measurement | 3.45e-04 | 11 | 75 | 2 | EFO_0801494 | |
| Disease | comparative body size at age 10, self-reported | 7.06e-04 | 420 | 75 | 6 | EFO_0009819 | |
| Disease | uric acid measurement | 9.18e-04 | 610 | 75 | 7 | EFO_0004761 | |
| Disease | Tachyarrhythmia | 9.50e-04 | 18 | 75 | 2 | C0080203 | |
| Disease | Tachycardia | 9.50e-04 | 18 | 75 | 2 | C0039231 | |
| Disease | total blood protein measurement | 9.97e-04 | 449 | 75 | 6 | EFO_0004536 | |
| Disease | white matter hyperintensity measurement | 1.04e-03 | 302 | 75 | 5 | EFO_0005665 | |
| Disease | Lung diseases | 1.05e-03 | 78 | 75 | 3 | C0024115 | |
| Disease | Osteogenesis imperfecta | 1.30e-03 | 21 | 75 | 2 | cv:C0029434 | |
| Disease | thyroid stimulating hormone measurement | 1.41e-03 | 323 | 75 | 5 | EFO_0004748 | |
| Disease | Parkinson disease | 1.42e-03 | 22 | 75 | 2 | cv:C0030567 | |
| Disease | serum urea measurement | 1.56e-03 | 195 | 75 | 4 | EFO_0009795 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.70e-03 | 24 | 75 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.70e-03 | 24 | 75 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 1.99e-03 | 26 | 75 | 2 | C0206698 | |
| Disease | cortical thickness | COL4A2 SHROOM3 ATXN2 COL21A1 CPSF6 TLX3 PKDCC HNRNPA1L3 PCDH7 | 2.02e-03 | 1113 | 75 | 9 | EFO_0004840 |
| Disease | retinal vasculature measurement | 2.04e-03 | 517 | 75 | 6 | EFO_0010554 | |
| Disease | eye measurement | 2.15e-03 | 27 | 75 | 2 | EFO_0004731 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RTSGGLHAYPGPRGG | 6 | Q7LC44 | |
| GGPRGRPGYDGCNGT | 126 | P08572 | |
| PGQKGSRGLDGYQGP | 316 | P08572 | |
| SRGLDGYQGPDGPRG | 321 | P08572 | |
| QAIGGYGPPPAGRGA | 241 | Q96EP5 | |
| GYFGTRAGPRLPRGA | 151 | Q9HA90 | |
| GQRGAGPGNSAYTPR | 211 | Q8N7S6 | |
| GPGNSAYTPRRSQGG | 216 | Q8N7S6 | |
| GGGLGAPLAAYRQGQ | 31 | P43699 | |
| SGPHGGGGQYFAKPR | 241 | A0A2R8Y4L2 | |
| AGNRAPGPRGSYLGG | 386 | A0AV96 | |
| PGPRGSYLGGYSAGR | 391 | A0AV96 | |
| GPGAGGAARLYRAGE | 46 | Q6ZRP7 | |
| AGGGYQAGSPQRSPG | 336 | Q9C0H5 | |
| GNLPHRGLQGPGLGY | 1896 | Q9HCM3 | |
| GPNGGMGDPYSRAAG | 1251 | O14497 | |
| GTGGGLLYGRESAPP | 166 | O43474 | |
| TNGLHARGYGPLGGR | 86 | Q9GZV7 | |
| GGRGRPGIRSYGPRD | 216 | Q9GZV7 | |
| GAAAYGARSPGGSPG | 256 | Q9UBI9 | |
| TGAGRGRYLPPVVGG | 431 | Q8N158 | |
| GGGRRGSNPVKRYAP | 36 | Q8N6Y2 | |
| FRGGRGGAHRGGFPP | 441 | Q9HCE5 | |
| RRSGRGGGGAAPGPY | 36 | Q99700 | |
| YNGSVGRPLGSGPGA | 6 | Q92952 | |
| LNIGGGGLGYRERPG | 651 | Q86XP3 | |
| GGLGYRERPGLGSEN | 656 | Q86XP3 | |
| FGNLPRPGRGARGGT | 361 | Q5JVS0 | |
| GRGAAPPRGRAGYSQ | 511 | O60506 | |
| PPRGRAGYSQRGGPG | 516 | O60506 | |
| AGYSQRGGPGSARGV | 521 | O60506 | |
| DRPGAGRGYNSIGRG | 211 | P55795 | |
| SRGGGGAGAFYPVPP | 71 | Q8N8D1 | |
| FTGKPGRAYGLGRPG | 21 | Q9BXM7 | |
| GRAYGLGRPGPAAGC | 26 | Q9BXM7 | |
| RRAGAADSAPYPGGG | 196 | O60245 | |
| LRRLGFGGPAGPGAS | 81 | A6NDG6 | |
| AASGGRGDLPYGPGR | 301 | P54826 | |
| RGDLPYGPGRRSSGG | 306 | P54826 | |
| YAVSKGPCRPGGGRG | 31 | Q9NSB4 | |
| DRPGAGRGYNSIGRG | 211 | P31943 | |
| IGFPGSRGLPGYAGR | 311 | P21757 | |
| SRGLPGYAGRPGNSG | 316 | P21757 | |
| RAPYRSGAGGPLGGR | 6 | Q86YD1 | |
| PGRRYLLLGGGPGAA | 521 | O00634 | |
| PGYFGQANGPAAGRG | 1006 | Q92900 | |
| YGGSIDSGPPGLLRG | 666 | Q9UKF2 | |
| GERGYPGNIGPVGAA | 946 | P08123 | |
| RGAGRGGPQQQGYMP | 396 | Q5SW24 | |
| AFPQGGRGRGRFPGA | 196 | Q16630 | |
| GYPGNRGAPGINGTK | 526 | P12109 | |
| RGAPGINGTKGYPGL | 531 | P12109 | |
| GSPGIQGARGLPGYK | 491 | Q96P44 | |
| QGARGLPGYKGEPGR | 496 | Q96P44 | |
| YGGRGKGGLPATLSP | 91 | Q6IS24 | |
| LYQGGRSGLPRGPRG | 291 | Q96G42 | |
| GDPGPASYGRNGRDG | 861 | P20849 | |
| YKGPARDPGGGAGAI | 741 | Q6ZRV2 | |
| GGGGGFQRYENRGPP | 621 | Q9BUJ2 | |
| AAGPGGTRSPRAGYL | 216 | Q6ZW31 | |
| GGPGGGAGVRSYPVI | 361 | P84550 | |
| SAREAYGAGPARGPG | 611 | P84550 | |
| ARGPGPGAGSGGYVS | 621 | P84550 | |
| SRRGPPPRRYGGGGY | 101 | Q01130 | |
| FPRTYGGRGGWPRGG | 86 | Q13242 | |
| EVQRYSRGGPGPGAG | 66 | Q504Y2 | |
| PNGGFQSGGSYHPGR | 191 | A4FU49 | |
| PGPSGRYGASGRSEG | 531 | O14545 | |
| GPGAYGGERPGVLAA | 16 | P78414 | |
| FRPYGLHGGEPGARG | 1201 | O14841 | |
| PGAFSGARPGLGGYS | 141 | Q5JWF2 | |
| GRGTQEGYPGGRPTC | 681 | Q8TF72 | |
| PQLPGLYGSAGRGSR | 371 | B8ZZ34 | |
| RGAGPPLAGSHYRGI | 51 | Q9NUC0 | |
| AEPPGGMQQGAGGYR | 21 | P20265 | |
| GNIGSPGYPGRQGLA | 591 | Q17RW2 | |
| GGGRGGDLYTFHPPA | 11 | Q9Y242 | |
| GVVGAGGPGPRYELR | 41 | Q5GH72 | |
| YQGRSPNAYGGGRGL | 916 | Q8N7X1 | |
| AKPPRGASTGGSGGY | 246 | Q8TDD2 | |
| YGLGGASPRGDPGLG | 756 | Q9C0C2 | |
| GGYPPRRDDRGGRQG | 916 | Q9H0D6 | |
| RRSLGAGYPHGNGSP | 86 | Q8WWA1 | |
| ASYLGGPPGGRPGAT | 41 | O43711 | |
| RGGSQPRAGTGYASP | 1131 | O43379 | |
| GGYNGRGWGSPGRPK | 1121 | A7E2V4 | |
| GGYSSACRPGPRAGG | 36 | Q9HCJ5 | |
| RALGGPCGPQGAYGQ | 191 | P20396 | |
| RGGPGSGGHGPLRYR | 1101 | Q8N1G0 | |
| RPLGSGLSGGSGFPY | 101 | O75604 | |
| GPYHRGRGGRGGNEP | 701 | Q96QC0 | |
| DERRGGGSLGSPYPG | 46 | Q9UL17 | |
| GGGYGCAPGLTRGPR | 131 | Q9Y5W3 |